Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Hair loss can cause significant emotional and psychological distress.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Ferulic acid helps stabilize vitamins C and E for better skin protection from the sun, certain compounds may promote hair growth, atopic dermatitis patients have lower skin defense molecules, older men are more likely to get a type of skin cancer, and a substance called relaxin may prevent age-related skin thickening.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Female pattern hair loss in Western India is common and often linked to metabolic syndrome.

The M-type is the most common form of male hair loss, and the BASP-classification is easy for different medical professionals to use.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

Men with severe hair loss may have a higher risk of heart disease.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

FOXN1 gene variants cause low T cells and immune issues from birth.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

Researchers found two new genetic variants linked to Alzheimer's disease.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.